首页> 外文期刊>Journal of Applied Biomaterials & Biomechanics >Efficacy of Bone Source~(TM) and Cementek~(TM) in comparison with Endobon~(TM) in critical size metaphyseal defects, using a minipig model
【24h】

Efficacy of Bone Source~(TM) and Cementek~(TM) in comparison with Endobon~(TM) in critical size metaphyseal defects, using a minipig model

机译:使用小型猪模型,Bone SourceTM和CementekTM与EndobonTM相比在临界大小的干defects端缺陷中的功效

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: To examine and compare biocompatibility, osteocompatibility, rate of resorption, and remodelling dynamics of 2 calcium phosphate cements in comparison with a well-established hydroxyapatite ceramic. Materials and methods: In a randomised fashion, Bone Source~(TM), Cementek~(TM), and Endobon~(TM) were implanted bilaterally into the proximal metaphyseal tibiae of 35 Gottinger minipigs in a direct right vs. left intra-individual comparison. Fluorescent labelling was used. Histological and morphometric evaluations were carried out at 6, 12, and 52 weeks. Results: All bone substitutes showed good biocompatibility, bioactivity, and osteoconductivity. Endobon~( TM) was not degraded over the follow-up period. Cementek~(TM) was degraded constantly and significantly over the time intervals, whereas Bone Source~(TM) was degraded mainly from the 6 week to 12 week interval. After 52 weeks, a significant difference of residual material within the defect zone was detected between all substitutes, with the highest resorption rate for Cementek~(TM). Bone Source~(TM) was least degraded. Defects filled with Endobon~(TM) were characterised by a significantly continuous bony ingrowth over the time intervals. Bone formation within the defects filled with Cementek~(TM) and Bone Source~(TM) showed significant peaks 12 weeks after implantation. After 52 weeks, a significant difference in the amount of new bone within the defect area was detected, with the highest levels for Endobon~(TM), followed by Cementek~(TM). Conclusion: After 1 year a restitutio ad integrum could not be observed in any treatment group. The ceramic Endobon~(TM) showed the expected response histologically. Based on its porosity it excelled in osteoconductivity. Concerning the calcium phosphate cements, a thorough osseous incorporation seemed to inhibit further degradation of both bone substitute materials.
机译:简介:与成熟的羟基磷灰石陶瓷相比,检查和比较2种磷酸钙水泥的生物相容性,骨相容性,吸收速率和重塑动力学。材料和方法:以随机的方式,将Bone SourceTM,CementekTM和EndobonTM分别从右侧个体与左侧个体分别向35只Gottinger小型猪的近端干phy端胫骨植入。比较。使用了荧光标记。在第6、12和52周进行组织学和形态计量学评估。结果:所有骨替代物均显示出良好的生物相容性,生物活性和骨传导性。 Endobon〜(TM)在后续期间未降解。在该时间间隔内,CementekTM持续且显着降解,而从6周到12周的时间间隔,Bone SourceTM则主要降解。 52周后,在所有替代品之间,缺陷区域内残留材料的差异明显,CementekTM的吸收率最高。 Bone SourceTM降级最少。充满EndobonTM的缺陷的特征在于在该时间间隔内骨骼连续向内生长。植入后12周,充满CementekTM和Bone SourceTM的缺损内的骨形成出现了明显的高峰。 52周后,发现缺损区域内新骨的数量存在显着差异,其中EndobonTM的含量最高,其次是CementekTM。结论:1年后,任何治疗组均未观察到恢复原状。陶瓷EndobonTM在组织学上显示出预期的响应。基于其孔隙率,其骨传导性优异。关于磷酸钙骨水泥,彻底的骨结合似乎抑制了两种骨替代材料的进一步降解。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号